FDA Import Refusal 1FX-4603720-7/10003/1 — CIPLA LIMITED
The FDA refused shipment 1FX-4603720-7/10003/1 from CIPLA LIMITED (India) on Sep 14, 2026. The refused product falls under Drugs and Biologics — MONTELUKAST SODIUM (ANTI-ASTHMATIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 14, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61EDK09 MONTELUKAST SODIUM (ANTI-ASTHMATIC)
- Charges
- 75